These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14592831)

  • 41. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.
    Kozak SL; Heard JM; Kabat D
    J Virol; 2002 Feb; 76(4):1802-15. PubMed ID: 11799176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41.
    Salzwedel K; Berger EA
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12794-9. PubMed ID: 11050186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells.
    Denizot M; Varbanov M; Espert L; Robert-Hebmann V; Sagnier S; Garcia E; Curriu M; Mamoun R; Blanco J; Biard-Piechaczyk M
    Autophagy; 2008 Nov; 4(8):998-1008. PubMed ID: 18818518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction.
    Ryser HJ; Levy EM; Mandel R; DiSciullo GJ
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4559-63. PubMed ID: 8183947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.
    Iyengar S; Schwartz DH; Hildreth JE
    J Immunol; 1999 May; 162(10):6263-7. PubMed ID: 10229873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4.
    Ugolini S; Moulard M; Mondor I; Barois N; Demandolx D; Hoxie J; Brelot A; Alizon M; Davoust J; Sattentau QJ
    J Immunol; 1997 Sep; 159(6):3000-8. PubMed ID: 9300725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection.
    Mañes S; del Real G; Lacalle RA; Lucas P; Gómez-Moutón C; Sánchez-Palomino S; Delgado R; Alcamí J; Mira E; Martínez-A C
    EMBO Rep; 2000 Aug; 1(2):190-6. PubMed ID: 11265761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential level in co-down-modulation of CD4 and CXCR4 primed by HIV-1 gp120 in response to phorbol ester, PMA, among HIV-1 isolates.
    Tahara-Hanaoka S; Ushijima Y; Tarui H; Wada M; Hara T; Imanishi S; Yamaguchi T; Hattori T; Nakauchi H; Koito A
    Microbiol Immunol; 2000; 44(6):489-98. PubMed ID: 10941932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion.
    Wang H; Barnes CO; Yang Z; Nussenzweig MC; Bjorkman PJ
    Cell Host Microbe; 2018 Oct; 24(4):579-592.e4. PubMed ID: 30308160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
    Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.
    Dimitrov AS; Xiao X; Dimitrov DS; Blumenthal R
    J Biol Chem; 2001 Aug; 276(32):30335-41. PubMed ID: 11397808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F; Borman AM; Brand D; Girard M
    AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.
    Popik W; Alce TM; Au WC
    J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional impact of HIV coreceptor-binding site mutations.
    Biscone MJ; Miamidian JL; Muchiri JM; Baik SS; Lee FH; Doms RW; Reeves JD
    Virology; 2006 Jul; 351(1):226-36. PubMed ID: 16631222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate.
    Verrier FC; Charneau P; Altmeyer R; Laurent S; Borman AM; Girard M
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9326-31. PubMed ID: 9256481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.
    Heredia JD; Park J; Choi H; Gill KS; Procko E
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.